GRT-C903,GRT-R904,nivolumab,ipilimumab
gritstone bio,bms
['$grts', 'gritstone ']
#gritstone presents positive initial phase 2 data in late-line #solidtumor patients treated with #kras directed #immunotherapy (#slate) at #esmo22 $grts 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.